{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:59:19Z","timestamp":1791453559584,"version":"4.3.3"},"reference-count":51,"publisher":"Pleiades Publishing Ltd","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1134\/s0006297926600079","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:14:59Z","timestamp":1779920099000},"page":"789-799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Conjugate of Aminoadamantane and Tetrahydro-\u03b3-Carboline Inhibits Accumulation of Mutant \u03b1-Synuclein A53T in the Cellular Model of Proteinopathy"],"prefix":"10.1134","volume":"91","author":[{"given":"Marina V.","family":"Burak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda E.","family":"Pukaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria S.","family":"Kryshkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Kukharskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya R.","family":"Nazdracheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey A.","family":"Pukhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill A.","family":"Rachenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla V.","family":"Stavrovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir P.","family":"Fisenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail S.","family":"Kukharsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei O.","family":"Bachurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"3038_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S. Koga","year":"2021","unstructured":"Koga, S., Sekiya, H., Kondru, N., Ross, O. A., and Dickson, D. W. (2021) Neuropathology and molecular diagnosis of synucleinopathies, Mol. Neurodegener., 16, 83, \nhttps:\/\/doi.org\/10.1186\/s13024-021-00501-z.","journal-title":"Mol. Neurodegener."},{"key":"3038_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"J. Q. Trojanowski","year":"1997","unstructured":"Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997) Alpha-synuclein in Lewy bodies, Nature, 388, 839-840, \nhttps:\/\/doi.org\/10.1038\/42166.","journal-title":"Nature"},{"key":"3038_CR3","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","volume":"90","author":"K. U\u00e9da","year":"1993","unstructured":"U\u00e9da, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., and Saitoh, T. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer\u2019s disease, Proc. Natl. Acad. Sci. USA, 90, 11282-11286, \nhttps:\/\/doi.org\/10.1073\/pnas.90.23.11282.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3038_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024091","volume":"8","author":"J. Burr\u00e9","year":"2018","unstructured":"Burr\u00e9, J., Sharma, M., and S\u00fcdhof, T. C. (2018) Cell biology and pathophysiology of \u03b1-synuclein, Cold Spring Harb. Perspect. Med., 8, a024091, \nhttps:\/\/doi.org\/10.1101\/cshperspect.a024091.","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"3038_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jnc.14810","volume":"150","author":"D. Sulzer","year":"2019","unstructured":"Sulzer, D., and Edwards, R. H. (2019) The physiological role of \u03b1-synuclein and its relationship to Parkinson's disease, J.\u00a0Neurochem., 150, 475-486, \nhttps:\/\/doi.org\/10.1111\/jnc.14810.","journal-title":"J.\u00a0Neurochem."},{"key":"3038_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.736978","volume":"8","author":"E. Srinivasan","year":"2021","unstructured":"Srinivasan, E., Chandrasekhar, G., Chandrasekar, P., Anbarasu, K., Vickram, A. S., Karunakaran, R., Rajasekaran, R., and Srikumar, P. S. (2021) Alpha-synuclein aggregation in Parkinson's disease, Front. Med., 8, 736978, \nhttps:\/\/doi.org\/10.3389\/fmed.2021.736978.","journal-title":"Front. Med."},{"key":"3038_CR7","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.bpj.2015.03.010","volume":"108","author":"Z. Lv","year":"2015","unstructured":"Lv, Z., Krasnoslobodtsev, A. V., Zhang, Y., Ysselstein, D., Rochet, J. C., Blanchard, S. C., and Lyubchenko, Y. L. (2015) Direct detection of \u03b1-synuclein dimerization dynamics: single-molecule fluorescence analysis, Biophys.\u00a0J., 108, 2038-2047, \nhttps:\/\/doi.org\/10.1016\/j.bpj.2015.03.010.","journal-title":"Biophys.\u00a0J."},{"key":"3038_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10789-6","volume":"12","author":"T. Ohgita","year":"2022","unstructured":"Ohgita, T., Namba, N., Kono, H., Shimanouchi, T., and Saito, H. (2022) Mechanisms of enhanced aggregation and fibril formation of Parkinson's disease-related variants of \u03b1-synuclein, Sci. Rep., 12, 6770, \nhttps:\/\/doi.org\/10.1038\/s41598-022-10789-6.","journal-title":"Sci. Rep."},{"key":"3038_CR9","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"K. A. Conway","year":"1998","unstructured":"Conway, K. A., Harper, J. D., and Lansbury, P. T. (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease, Nat. Med., 4, 1318-1320, \nhttps:\/\/doi.org\/10.1038\/3311.","journal-title":"Nat. Med."},{"key":"3038_CR10","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"M. H. Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di Iorio, G., Golbe, L. I., and Nussbaum, R. L. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, 276, 2045-2047, \nhttps:\/\/doi.org\/10.1126\/science.276.5321.2045.","journal-title":"Science"},{"key":"3038_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13030573","volume":"13","author":"N. Shusharina","year":"2023","unstructured":"Shusharina, N., Yukhnenko, D., Botman, S., Sapunov, V., Savinov, V., Kamyshov, G., Sayapin, D., and Voznyuk, I. (2023) Modern methods of diagnostics and treatment of neurodegenerative diseases and depression, Diagnostics, 13, 573, \nhttps:\/\/doi.org\/10.3390\/diagnostics13030573.","journal-title":"Diagnostics"},{"key":"3038_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnrt.2024.100176","volume":"13","author":"W. Gao","year":"2025","unstructured":"Gao, W., Jing, S., He, C., Saberi, H., Sharma, H. S., Han, F., and Chen, L. (2025) Advancements in neurodegenerative diseases: Pathogenesis and novel neurorestorative interventions, J.\u00a0Neurorestoratol., 13, 100176, \nhttps:\/\/doi.org\/10.1016\/j.jnrt.2024.100176.","journal-title":"J.\u00a0Neurorestoratol."},{"key":"3038_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00797-1","volume":"20","author":"G. Kuo","year":"2025","unstructured":"Kuo, G., Kumbhar, R., Blair, W., Dawson, V. L., Dawson, T. M., and Mao, X. (2025) Emerging targets of \u03b1-synuclein spreading in \u03b1-synucleinopathies: a review of mechanistic pathways and interventions, Mol. Neurodegener., 20, 10, \nhttps:\/\/doi.org\/10.1186\/s13024-025-00797-1.","journal-title":"Mol. Neurodegener."},{"key":"3038_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1468850","volume":"15","author":"K. Yang","year":"2024","unstructured":"Yang, K., Lv, Z., Zhao, W., Lai, G., Zheng, C., Qi, F., Zhao, C., Hu, K., Chen, X., Fu, F., Li, J., Xie, G., Wang, H., Wu, X., and Zheng, W. (2024) The potential of natural products to inhibit abnormal aggregation of \u03b1-synuclein in the treatment of Parkinson's disease, Front. Pharmacol., 15, 1468850, \nhttps:\/\/doi.org\/10.3389\/fphar.2024.1468850.","journal-title":"Front. Pharmacol."},{"key":"3038_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102538","volume":"101","author":"I. A. Ahanger","year":"2024","unstructured":"Ahanger, I. A., and Dar, T. A. (2024) Small molecule modulators of alpha-synuclein aggregation and toxicity: pioneering an emerging arsenal against Parkinson's disease, Ageing Res. Rev., 101, 102538, \nhttps:\/\/doi.org\/10.1016\/j.arr.2024.102538.","journal-title":"Ageing Res. Rev."},{"key":"3038_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10787-017-0402-8","volume":"26","author":"N. Sharma","year":"2018","unstructured":"Sharma, N., and Nehru, B. (2018) Curcumin affords neuroprotection and inhibits \u03b1-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model, Inflammopharmacology, 26, 349-360, \nhttps:\/\/doi.org\/10.1007\/s10787-017-0402-8.","journal-title":"Inflammopharmacology"},{"key":"3038_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-3-319-18365-7_7","volume":"863","author":"K. Andrich","year":"2015","unstructured":"Andrich, K., and Bieschke, J. (2015) The effect of (-)-Epigallo-catechin-(3)-gallate on amyloidogenic proteins suggests a common mechanism, Adv. Exp. Med. Biol., 863, 139-161, \nhttps:\/\/doi.org\/10.1007\/978-3-319-18365-7_7.","journal-title":"Adv. Exp. Med. Biol."},{"key":"3038_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26123736","volume":"26","author":"S. S. Ghanem","year":"2021","unstructured":"Ghanem, S. S., Fayed, H. S., Zhu, Q., Lu, J. H., Vaikath, N. N., Ponraj, J., Mansour, S., and El-Agnaf, O. M. A. (2021) Natural alkaloid compounds as inhibitors for alpha-synuclein seeded fibril formation and toxicity, Molecules, 26, 3736, \nhttps:\/\/doi.org\/10.3390\/molecules26123736.","journal-title":"Molecules"},{"key":"3038_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1080\/10286020.2022.2104259","volume":"25","author":"T. Y. Lee","year":"2023","unstructured":"Lee, T. Y., Yang, W., Cha, D. S., and Han, Y. T. (2023) Synthesis of a natural quinoline alkaloid isolated from the deep-sea-derived fungus and its potential as a therapeutic for Parkinson's disease, J.\u00a0As. Nat. Prod. Res., 25, 446-455, \nhttps:\/\/doi.org\/10.1080\/10286020.2022.2104259.","journal-title":"J.\u00a0As. Nat. Prod. Res."},{"key":"3038_CR20","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.1073\/pnas.1804198115","volume":"115","author":"J. Pujols","year":"2018","unstructured":"Pujols, J., Pe\u00f1a-D\u00edaz, S., L\u00e1zaro, D. F., Peccati, F., Pinheiro, F., Gonz\u00e1lez, D., Carija, A., Navarro, S., Conde-Gim\u00e9nez, M., Garc\u00eda, J., Guardiola, S., Giralt, E., Salvatella, X., Sancho, J., Sodupe, M., Outeiro, T. F., Dalf\u00f3, E., and Ventura, S. (2018) Small molecule inhibits \u03b1-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons, Proc. Natl. Acad. Sci. USA, 115, 10481-10486, \nhttps:\/\/doi.org\/10.1073\/pnas.1804198115.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3038_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101902","volume":"298","author":"S. Pe\u00f1a-D\u00edaz","year":"2022","unstructured":"Pe\u00f1a-D\u00edaz, S., Pujols, J., Vasili, E., Pinheiro, F., Santos, J., Manglano-Artu\u00f1edo, Z., Outeiro, T. F., and Ventura, S. (2022) The small aromatic compound SynuClean-D inhibits the\u00a0aggregation and seeded polymerization of multiple \u03b1-synuclein strains, J.\u00a0Biol. Chem., 298, 101902, \nhttps:\/\/doi.org\/10.1016\/j.jbc.2022.101902.","journal-title":"J.\u00a0Biol. Chem."},{"key":"3038_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00702-010-0513-5","volume":"118","author":"J. T. Rogers","year":"2011","unstructured":"Rogers, J. T., Mikkilineni, S., Cantuti-Castelvetri, I., Smith, D. H., Huang, X., Bandyopadhyay, S., Cahill, C. M., Maccecchini, M. L., Lahiri, D. K., and Greig, N. H. (2011) The alpha-synuclein 5\u2032untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen, J.\u00a0Neural Transmission, 118, 493-507, \nhttps:\/\/doi.org\/10.1007\/s00702-010-0513-5.","journal-title":"J.\u00a0Neural Transmission"},{"key":"3038_CR23","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/ijms10031226","volume":"10","author":"D. Olivares","year":"2009","unstructured":"Olivares, D., Huang, X., Branden, L., Greig, N. H., and Rogers, J. T. (2009) Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element, Int.\u00a0J. Mol. Sci., 10, 1226-1260, \nhttps:\/\/doi.org\/10.3390\/ijms10031226.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"3038_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/142372","volume":"2012","author":"S. Mikkilineni","year":"2012","unstructured":"Mikkilineni, S., Cantuti-Castelvetri, I., Cahill, C. M., Balliedier, A., Greig, N. H., and Rogers, J. T. (2012) The anticholinesterase phenserine and its enantiomer posiphen as 5\u2032untranslated-region-directed translation blockers of the Parkinson\u2019s alpha synuclein expression, Parkinsons Dis., 2012, 142372, \nhttps:\/\/doi.org\/10.1155\/2012\/142372.","journal-title":"Parkinsons Dis."},{"key":"3038_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1871523011312020003","volume":"12","author":"Q. S. Yu","year":"2013","unstructured":"Yu, Q. S., Reale, M., Kamal, M. A., Holloway, H. W., Luo, W., Sambamurti, K., Ray, B., Lahiri, D. K., Rogers, J. T., and Greig, N. H. (2013) Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, \u03b1-Synuclein synthesis, interleukin-1\u03b2 release, and cholinergic action, Anti Inflamm. Anti Allergy Agents Med. Chem., 12, 117-128, \nhttps:\/\/doi.org\/10.2174\/1871523011312020003.","journal-title":"Anti Inflamm. Anti Allergy Agents Med. Chem."},{"key":"3038_CR26","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1136\/jnnp-2012-302589","volume":"83","author":"M. L. Maccecchini","year":"2012","unstructured":"Maccecchini, M. L., Chang, M. Y., Pan, C., John, V., Zetterberg, H., and Greig, N. H. (2012) Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-\u03b2 peptide and \u03c4 levels: target engagement, tolerability and pharmacokinetics in humans, J.\u00a0Neurol. Neurosurg. Psychiatry, 83, 894-902, \nhttps:\/\/doi.org\/10.1136\/jnnp-2012-302589.","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"3038_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-0-306-47593-1_35","volume":"51","author":"D. Lahiri","year":"2002","unstructured":"Lahiri, D., Utsuki, T., Shaw, K., Ge, Y.-W., Sambamurti, K., Eder, P., Rogers, J., Farlow, M., Giordino, T., and Greig, N. (2002) Phenserine regulates translation of \u00df-amyloid precursor protein message, Mapp. Progr. Alzheimers Parkinsons Dis., 51, 211-215, \nhttps:\/\/doi.org\/10.1007\/978-0-306-47593-1_35.","journal-title":"Mapp. Progr. Alzheimers Parkinsons Dis."},{"key":"3038_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00702-021-02306-2","volume":"128","author":"W. Danysz","year":"2021","unstructured":"Danysz, W., Dekundy, A., Scheschonka, A., and Riederer, P. (2021) Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials, J.\u00a0Neural Transmiss., 128, 127-169, \nhttps:\/\/doi.org\/10.1007\/s00702-021-02306-2.","journal-title":"J.\u00a0Neural Transmiss."},{"key":"3038_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003468","volume":"2003","author":"N. Crosby","year":"2003","unstructured":"Crosby, N., Deane, K. H., and Clarke, C. E. (2003) Amantadine in Parkinson's disease, Cochrane database System. Rev., 2003, CD003468, \nhttps:\/\/doi.org\/10.1002\/14651858.CD003468.","journal-title":"Cochrane database System. Rev."},{"key":"3038_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.32607\/20758251-2018-10-4-59-62","volume":"10","author":"V. I. Skvortsova","year":"2018","unstructured":"Skvortsova, V. I., Bachurin, S. O., Ustyugov, A. A., Kukharsky, M. S., Deikin, A. V., Buchman, V. L., and Ninkina, N. N. (2018) Prospects for the use of gamma-carbolines in the development of pathogenetic therapy for proteinopathies, Acta Naturae, 10, 54-57, \nhttps:\/\/doi.org\/10.32607\/20758251-2018-10-4-59-62.","journal-title":"Acta Naturae"},{"key":"3038_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1134\/s1607672909050032","volume":"428","author":"S. O. Bachurin","year":"2009","unstructured":"Bachurin, S. O., Ustyugov, A. A., Peters, O., Shelkovnikova, T. A., Buchman, V. L., and Ninkina, N. N. (2009) Hindering of proteinopathy-induced neurodegeneration as a new mechanism of action for neuroprotectors and cognition enhancing compounds, Dokl. Biochem. Biophys., 428, 235-238, \nhttps:\/\/doi.org\/10.1134\/s1607672909050032.","journal-title":"Dokl. Biochem. Biophys."},{"key":"3038_CR32","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.2174\/0929867323666160804122746","volume":"25","author":"A. Ustyugov","year":"2018","unstructured":"Ustyugov, A., Shevtsova, E., Ashraf, G. M., Tarasov, V. V., Bachurin, S. O., and Aliev, G. (2018) New therapeutic property of Dimebon as a neuroprotective agent, Curr. Med. Chem., 25, 5315-5326, \nhttps:\/\/doi.org\/10.2174\/0929867323666160804122746.","journal-title":"Curr. Med. Chem."},{"key":"3038_CR33","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10517-012-1618-7","volume":"152","author":"A. A. Ustyugov","year":"2012","unstructured":"Ustyugov, A. A., Shelkovnikova, T. A., Kokhan, V. S., Khritankova, I. V., Peters, O., Buchman, V. L., Bachurin, S. O., and Ninkina, N. N. (2012) Dimebon reduces the levels of aggregated amyloidogenic protein forms in detergent-insoluble fractions in vivo, Bull. Exp. Biol. Med., 152, 731-733, \nhttps:\/\/doi.org\/10.1007\/s10517-012-1618-7.","journal-title":"Bull. Exp. Biol. Med."},{"key":"3038_CR34","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-2012-121732","volume":"33","author":"O. M. Peters","year":"2013","unstructured":"Peters, O. M., Connor-Robson, N., Sokolov, V. B., Aksinenko, A. Y., Kukharsky, M. S., Bachurin, S. O., Ninkina, N., and Buchman, V. L. (2013) Chronic administration of dimebon ameliorates pathology in TauP301S transgenic mice, J.\u00a0Alzheimers Dis., 33, 1041-1049, \nhttps:\/\/doi.org\/10.3233\/JAD-2012-121732.","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"3038_CR35","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1016\/j.febslet.2009.06.042","volume":"583","author":"M. Yamashita","year":"2009","unstructured":"Yamashita, M., Nonaka, T., Arai, T., Kametani, F., Buchman, V. L., Ninkina, N., Bachurin, S. O., Akiyama, H., Goedert, M., and Hasegawa, M. (2009) Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models, FEBS Lett., 583, 2419-2424, \nhttps:\/\/doi.org\/10.1016\/j.febslet.2009.06.042.","journal-title":"FEBS Lett."},{"key":"3038_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-3-15","volume":"3","author":"J. Wu","year":"2008","unstructured":"Wu, J., Li, Q., and Bezprozvanny, I. (2008) Evaluation of Dimebon in cellular model of Huntington\u2019s disease, Mol. Neurodegener., 3, 15, \nhttps:\/\/doi.org\/10.1186\/1750-1326-3-15.","journal-title":"Mol. Neurodegener."},{"key":"3038_CR37","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/s12035-015-9249-4","volume":"52","author":"A. Ustyugov","year":"2015","unstructured":"Ustyugov, A., Shevtsova, E., and Bachurin, S. (2015) Novel sites of neuroprotective action of Dimebon (Latrepirdine), Mol. Neurobiol., 52, 970-978, \nhttps:\/\/doi.org\/10.1007\/s12035-015-9249-4.","journal-title":"Mol. Neurobiol."},{"key":"3038_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26185527","volume":"26","author":"S. O. Bachurin","year":"2021","unstructured":"Bachurin, S. O., Makhaeva, G. F., Shevtsova, E. F., Aksinenko, A. Y., Grigoriev, V. V., Shevtsov, P. N., Goreva, T. V., Epishina, T. A., Kovaleva, N. V., Pushkareva, E. A., Boltneva, N. P., Lushchekina, S. V., Gabrelyan, A. V., Zamoyski, V. L., Dubova, L. G., Rudakova, E. V., Fisenko, V. P., Bovina, E. V., and Richardson, R. J. (2021) Conjugation of aminoadamantane and \u03b3-carboline pharmacophores gives rise to unexpected properties of multifunctional ligands, Molecules, 26, 5527, \nhttps:\/\/doi.org\/10.3390\/molecules26185527.","journal-title":"Molecules"},{"key":"3038_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30010198","volume":"30","author":"S. A. Pukhov","year":"2025","unstructured":"Pukhov, S. A., Semakov, A. V., Pukaeva, N. E., Kukharskaya, O. A., Ivanova, T. V., Kryshkova, V. S., Bachurin, S. O., and Kukharsky, M. S. (2025) Artemisinin stimulates neuronal cell viability and possess a neuroprotective effect in\u00a0vitro, Molecules, 30, 198, \nhttps:\/\/doi.org\/10.3390\/molecules30010198.","journal-title":"Molecules"},{"key":"3038_CR40","first-page":"29","volume":"69","author":"N. E. Pukaeva","year":"2025","unstructured":"Pukaeva, N. E., Kukharskaya, O. A., Ivanova, T. V., Nazdracheva, M. R., Burak, M. V., Popov, A. A., Ovchinnikov, R. K., Antokhin, A. I., Moskovtsev, A. A., and Kukharsky, M. S. (2025) Aggregation of the mutant \u03b1-synuclein A53T protein in SH-SY5Y neuronal cells: model validation [in Russian], Pathol. Physiol. Exp. Ther., 69, 29-41.","journal-title":"Pathol. Physiol. Exp. Ther."},{"key":"3038_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neulet.2014.02.056","volume":"566","author":"Y. Bang","year":"2014","unstructured":"Bang, Y., Kang, B. Y., and Choi, H. J. (2014) Preconditioning stimulus of proteasome inhibitor enhances aggresome formation and autophagy in differentiated SH-SY5Y cells, Neurosci. Lett., 566, 263-268, \nhttps:\/\/doi.org\/10.1016\/j.neulet.2014.02.056.","journal-title":"Neurosci. Lett."},{"key":"3038_CR42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jns.2011.04.015","volume":"307","author":"Y. M. Kim","year":"2011","unstructured":"Kim, Y. M., Jang, W. H., Quezado, M. M., Oh, Y., Chung, K. C., Junn, E., and Mouradian, M. M. (2011) Proteasome inhibition induces \u03b1-synuclein SUMOylation and aggregate formation, J.\u00a0Neurol. Sci., 307, 157-161, \nhttps:\/\/doi.org\/10.1016\/j.jns.2011.04.015.","journal-title":"J.\u00a0Neurol. Sci."},{"key":"3038_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00039","volume":"7","author":"G. Mercado","year":"2015","unstructured":"Mercado, G., Castillo, V., Vidal, R., and Hetz, C. (2015) ER proteostasis disturbances in Parkinson's disease: novel insights, Front. Aging Neurosci., 7, 39, \nhttps:\/\/doi.org\/10.3389\/fnagi.2015.00039.","journal-title":"Front. Aging Neurosci."},{"key":"3038_CR44","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1093\/hmg\/ddi396","volume":"14","author":"W. W. Smith","year":"2005","unstructured":"Smith, W. W., Jiang, H., Pei, Z., Tanaka, Y., Morita, H., Sawa, A., Dawson, V. L., Dawson, T. M., and Ross, C. A. (2005) Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity, Hum. Mol. Genet., 14, 3801-3811, \nhttps:\/\/doi.org\/10.1093\/hmg\/ddi396.","journal-title":"Hum. Mol. Genet."},{"key":"3038_CR45","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1523\/JNEUROSCI.5367-11.2012","volume":"32","author":"E. Colla","year":"2012","unstructured":"Colla, E., Coune, P., Liu, Y., Pletnikova, O., Troncoso, J. C., Iwatsubo, T., Schneider, B. L., and Lee, M. K. (2012) Endoplasmic reticulum stress is important for the manifestations of \u03b1-synucleinopathy in\u00a0vivo, J.\u00a0Neurosci., 32, 3306-3320, \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.5367-11.2012.","journal-title":"J.\u00a0Neurosci."},{"key":"3038_CR46","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"S. C. Ling","year":"2013","unstructured":"Ling, S. C., Polymenidou, M., and Cleveland, D. W. (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis, Neuron, 79, 416-438, \nhttps:\/\/doi.org\/10.1016\/j.neuron.2013.07.033.","journal-title":"Neuron"},{"key":"3038_CR47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/15476286.2021.1963099","volume":"18","author":"G. A. Corbet","year":"2021","unstructured":"Corbet, G. A., Wheeler, J. R., Parker, R., and Weskamp, K. (2021) TDP43 ribonucleoprotein granules: physiologic function to pathologic aggregates, RNA Biol., 18, 128-138, \nhttps:\/\/doi.org\/10.1080\/15476286.2021.1963099.","journal-title":"RNA Biol."},{"key":"3038_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00025","volume":"12","author":"A. Prasad","year":"2019","unstructured":"Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., and Patel, B. K. (2019) Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis, Front. Mol. Neurosci., 12, 25, \nhttps:\/\/doi.org\/10.3389\/fnmol.2019.00025.","journal-title":"Front. Mol. Neurosci."},{"key":"3038_CR49","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M. Neumann","year":"2006","unstructured":"Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., McCluskey, L. F., Miller, B. L., Masliah, E., Mackenzie, I. R., Feldman, H., Feiden, W., Kretzschmar, H. A., Trojanowski, J. Q., and Lee, V. M. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130-133, \nhttps:\/\/doi.org\/10.1126\/science.1134108.","journal-title":"Science"},{"key":"3038_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00084","volume":"7","author":"S. R. Chadwick","year":"2019","unstructured":"Chadwick, S. R., and Lajoie, P. (2019) Endoplasmic reticulum stress coping mechanisms and lifespan regulation in health and diseases, Front. Cell Dev. Biol., 7, 84, \nhttps:\/\/doi.org\/10.3389\/fcell.2019.00084.","journal-title":"Front. Cell Dev. Biol."},{"key":"3038_CR51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ana.23746","volume":"73","author":"L. V. Kalia","year":"2013","unstructured":"Kalia, L. V., Kalia, S. K., McLean, P. J., Lozano, A. M., and Lang, A. E. (2013) \u03b1-Synuclein oligomers and clinical implications for Parkinson disease, Ann. Neurol., 73, 155-169, \nhttps:\/\/doi.org\/10.1002\/ana.23746.","journal-title":"Ann. Neurol."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926600079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297926600079","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926600079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:15:00Z","timestamp":1779920100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297926600079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["3038"],"URL":"https:\/\/doi.org\/10.1134\/s0006297926600079","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      This work does not contain any studies involving human and animal subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}